Comvita Limited (CVNZF)
OTCMKTS · Delayed Price · Currency is USD
0.4030
0.00 (0.00%)
At close: Feb 3, 2026
Comvita Revenue
In the fiscal year ending June 30, 2025, Comvita had annual revenue of 192.43M NZD, down -4.11%. Comvita had revenue of 92.72M in the half year ending June 30, 2025, a decrease of -24.04%.
Revenue
192.43M NZD
Revenue Growth
-4.11%
P/S Ratio
0.24
Revenue / Employee
481.07K NZD
Employees
400
Market Cap
27.71M USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 192.43M | -8.26M | -4.11% |
| Jun 30, 2024 | 200.68M | -33.51M | -14.31% |
| Jun 30, 2023 | 234.20M | 25.29M | 12.10% |
| Jun 30, 2022 | 208.91M | 17.18M | 8.96% |
| Jun 30, 2021 | 191.73M | -4.18M | -2.13% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hanover Foods | 330.81M |
| Elamex SA de CV | 110.74M |
| Integrated BioPharma | 53.43M |
| Starco Brands | 47.15M |
| DAVIDsTEA | 43.33M |
| Global Pharmatech | 3.18M |
| Limitless X Holdings | 1.13M |
| China Foods Holdings | 422.40K |
Comvita News
- 6 weeks ago - Comvita Limited (CVNZF) Shareholder/Analyst Call - Slideshow - Seeking Alpha
- 2 months ago - Comvita Limited (CVNZF) Shareholder/Analyst Call Transcript - Seeking Alpha